Pharmaceutical company Pharmaxis (ASX: PXS, Nasdaq: PXSL) today announced the appointment of the U.S. life science investment manager Richard van den Broek to its Board of Directors.

Full Release - New Pharmaxis Board Appointment: Richard van den Broek